These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12045481)

  • 1. The corticotropin-releasing factor/urocortin system and alcohol.
    Ryabinin AE; Bachtell RK; Heinrichs SC; Lee S; Rivier C; Olive MF; Mehmert KK; Camarini R; Kim JA; Koenig HN; Nannini MA; Hodge CW; Roberts AJ; Koob GF
    Alcohol Clin Exp Res; 2002 May; 26(5):714-22. PubMed ID: 12045481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
    Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
    Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Urocortin to the Development of Excessive Drinking.
    Ryabinin AE; Giardino WJ
    Int Rev Neurobiol; 2017; 136():275-291. PubMed ID: 29056154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiological processes in alcohol addiction.
    Lê AD; Kiianmaa K; Cunningham CL; Engel JA; Ericson M; Söderpalm B; Koob GF; Roberts AJ; Weiss F; Hyytiä P; Janhunen S; Mikkola J; Bäckström P; Ponomarev I; Crabbe JC
    Alcohol Clin Exp Res; 2001 May; 25(5 Suppl ISBRA):144S-151S. PubMed ID: 11391064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.
    Ryabinin AE; Tsoory MM; Kozicz T; Thiele TE; Neufeld-Cohen A; Chen A; Lowery-Gionta EG; Giardino WJ; Kaur S
    Alcohol; 2012 Jun; 46(4):349-57. PubMed ID: 22444954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
    Henry BA; Lightman SL; Lowry CA
    J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption.
    Ryabinin AE; Weitemier AZ
    Brain Res Rev; 2006 Sep; 52(2):368-80. PubMed ID: 16766036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New neuronal networks involved in ethanol reinforcement.
    Kiianmaa K; Hyytiä P; Samson HH; Engel JA; Svensson L; Söderpalm B; Larsson A; Colombo G; Vacca G; Finn DA; Bachtell RK; Ryabinin AE
    Alcohol Clin Exp Res; 2003 Feb; 27(2):209-19. PubMed ID: 12605070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the endogenous opioid system on the neuropsychopharmacological effects of ethanol: new insights about an old question.
    Sanchis-Segura C; Grisel JE; Olive MF; Ghozland S; Koob GF; Roberts AJ; Cowen MS
    Alcohol Clin Exp Res; 2005 Aug; 29(8):1522-7. PubMed ID: 16156049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression.
    Lee S; Smith GW; Vale W; Lee KF; Rivier C
    Alcohol Clin Exp Res; 2001 Mar; 25(3):427-33. PubMed ID: 11290855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hypothalamic corticotropin-releasing factor in mediating alcohol-induced activation of the rat hypothalamic-pituitary-adrenal axis.
    Rivier C
    Front Neuroendocrinol; 2014 Apr; 35(2):221-33. PubMed ID: 24211830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Jászberényi M; Telegdy G
    Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin 1 in the dorsal raphe regulates food and fluid consumption, but not ethanol preference in C57BL/6J mice.
    Weitemier AZ; Ryabinin AE
    Neuroscience; 2006; 137(4):1439-45. PubMed ID: 16338088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of gonadotropin-releasing hormone by corticotropin-releasing factor family peptides in hypothalamic N39 cells.
    Kageyama K; Hasegawa G; Akimoto K; Yamagata S; Tamasawa N; Suda T
    Peptides; 2012 Jan; 33(1):149-55. PubMed ID: 22138165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.